K U 712
Pill imprint K U 712 has been identified as Moexipril and hydrochlorothiazide 7.5 mg / 12.5 mg.
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Hydrochlorothiazide/moexipril 7.5 mg / 12.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Moexipril and hydrochlorothiazide Images
- Imprint:
-
K U
712 - Strength:
- 7.5 mg / 12.5 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Figure eight-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cobalt Laboratories Inc
- National Drug Code (NDC):
- 16252-0612
Advertisement
More Moexipril and Hydrochlorothiazide resources
- Hydrochlorothiazide/Moexipril (Wolters Kluwer)
- Moexipril/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and moexipril (Cerner Multum)
- moexipril and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Moexipril and Hydrochlorothiazide (FDA)
Search Again
